Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gaudet

Showing results (21-30 of 304) with videos related to

Pageof 31
Sort By:
BMC Medical Genetics|April 3, 2010
Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technologyFrançois W Paradis, Raynald Simard, Daniel Gaudet
The New England Journal of Medicine|February 10, 2021
Evinacumab for Homozygous Familial Hypercholesterolemia. ReplyFrederick J Raal, Daniel Gaudet, Viktoria Gusarova
Future Cardiology|April 26, 2022
Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemiaEtienne Khoury, Laurent Croteau, Alex Lauzière, et al.
Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes|August 15, 2015
Development of a real-time immuno-PCR assay for the quantification of 17β-estradiol in waterDaniel Gaudet, Denise Nilsson, Tanner Lohr, et al.
The Canadian Journal of Cardiology|April 3, 2017
Lipid Metabolism and Emerging Targets for Lipid-Lowering TherapyDaniel Gaudet, Jean-Philippe Drouin-Chartier, Patrick Couture
Journal of Clinical Lipidology|January 26, 2011
Etiology and risk of lactescent plasma and severe hypertriglyceridemiaKarine Tremblay, Julie Méthot, Diane Brisson, et al.
Journal of Clinical Lipidology|April 4, 2026
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemiaMiriam Larouche, Diane Brisson, Catherine Laprise, et al.
Nature Reviews. Cardiology|March 25, 2026
ApoC-III inhibition: from regulatory approval to equitable implementationDaniel Gaudet, Miriam Larouche, Erik S G Stroes
JAMA|June 19, 2008
The ENHANCE study and marketing ezetimibeFatima Akdim, John J P Kastelein, Daniel Gaudet
Current Atherosclerosis Reports|December 14, 2023
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe HypertriglyceridemiaMiriam Larouche, Etienne Khoury, Diane Brisson, et al.
Pageof 31

Showing results (21-30 of 304) with videos related to

Sort By:
Pageof 31
BMC Medical Genetics|April 3, 2010
Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technologyFrançois W Paradis, Raynald Simard, Daniel Gaudet
The New England Journal of Medicine|February 10, 2021
Evinacumab for Homozygous Familial Hypercholesterolemia. ReplyFrederick J Raal, Daniel Gaudet, Viktoria Gusarova
Future Cardiology|April 26, 2022
Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemiaEtienne Khoury, Laurent Croteau, Alex Lauzière, et al.
Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes|August 15, 2015
Development of a real-time immuno-PCR assay for the quantification of 17β-estradiol in waterDaniel Gaudet, Denise Nilsson, Tanner Lohr, et al.
The Canadian Journal of Cardiology|April 3, 2017
Lipid Metabolism and Emerging Targets for Lipid-Lowering TherapyDaniel Gaudet, Jean-Philippe Drouin-Chartier, Patrick Couture
Journal of Clinical Lipidology|January 26, 2011
Etiology and risk of lactescent plasma and severe hypertriglyceridemiaKarine Tremblay, Julie Méthot, Diane Brisson, et al.
Journal of Clinical Lipidology|April 4, 2026
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemiaMiriam Larouche, Diane Brisson, Catherine Laprise, et al.
Nature Reviews. Cardiology|March 25, 2026
ApoC-III inhibition: from regulatory approval to equitable implementationDaniel Gaudet, Miriam Larouche, Erik S G Stroes
JAMA|June 19, 2008
The ENHANCE study and marketing ezetimibeFatima Akdim, John J P Kastelein, Daniel Gaudet
Current Atherosclerosis Reports|December 14, 2023
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe HypertriglyceridemiaMiriam Larouche, Etienne Khoury, Diane Brisson, et al.
Pageof 31